Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ureter drugs].

G Raynal1, J Bellan, F Saint

  • 1Service d'urologie et transplantation, CHU d'Amiens, hôpital Sud, boulevard Laennec, 80054 Salouel cedex, France. gauthier.raynal@etud.u-picardie.fr

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|May 13, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Infections and male infertility].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

2022 Recommendations of the AFU Lithiasis Committee: Management of symptomatic urinary stones.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

2022 Recommendations of the AFU Lithiasis Committee: Ureteroscopy and ureterorenoscopy.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

2022 recommendations of the AFU Lithiasis Committee: Objectives, results, residual stones and fragments.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

[Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same journal

["Connected device for monitoring patients treated by prostatectomy: Implementation and qualitative assessment"].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Role of nurses specializing in oncology to support the care journey for patients with penile cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Pre- and post-prostatectomy rehabilitation by the certified nurse-urologist pair (REHAB): Feasibility study].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Genitourinary complications after pelvic radiotherapy: Diagnosis and management].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same journal

[Male contraception].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
See all related articles

Recent advancements in ureteral smooth muscle pharmacology offer new drug therapies. Non-steroidal anti-inflammatory drugs (NSAIDs) and alpha-blockers show promise for renal colic and stone expulsion, with further research needed for beta-agonists and topical agents.

Area of Science:

  • Pharmacology
  • Urology
  • Smooth Muscle Physiology

Context:

  • Ureteral smooth muscle function is crucial for urine transport.
  • Pharmacological interventions can modulate ureteral activity.
  • Recent advancements have expanded therapeutic options.

Purpose:

  • To review the current understanding of ureteral smooth muscle pharmacology.
  • To explore the clinical applications of various drug classes in urological conditions.
  • To identify areas for future research and drug development.

Summary:

  • This review covers the physiological basis of ureteral smooth muscle.
  • It examines the effects of different drug classes on ureteral function.
  • Clinical applications discussed include renal colic analgesia, medical expulsive therapy for calculi, extracorporeal shock wave lithotripsy (ESWL) adjuvant treatment, and preoperative management for retrograde access.

Related Experiment Videos

  • Current evidence supports the use of non-steroidal anti-inflammatory drugs (NSAIDs) and alpha-blockers.
  • Beta-agonists, particularly selective beta3 agonists, and topical agents warrant further investigation.

    • Impact:

    • Provides a comprehensive overview of ureteral pharmacology for clinicians and researchers.
    • Highlights evidence-based treatments and identifies gaps in current knowledge.
    • Informs future research directions for novel ureteral drug therapies.
    • Aims to improve patient outcomes in conditions like renal colic and urinary stone disease.